Dimerix Ltd (ASX: DXB) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Dimerix Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Dimerix Ltd (ASX: DXB)
Latest News
![A young boy in a business suit lifts his glasses above his eyes and gives a big wide mouthed smile to the camera with a stock market board in the background.](https://www.fool.com.au/wp-content/uploads/2021/10/shares-boy-16_9-400x225.jpg)
Share Market News
Top 10 most traded ASX shares and US stocks in June
![A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.](https://www.fool.com.au/wp-content/uploads/2022/05/miffed-16.9-400x225.jpg)
Share Fallers
Why Dimerix, New Hope, Pro Medicus, and West African Resources shares are sinking today
![Woman looks amazed and shocked as she looks at her laptop.](https://www.fool.com.au/wp-content/uploads/2022/03/amazed-16_9-400x225.jpg)
Share Gainers
If you invested $5,000 in this ASX healthcare stock a year ago, you'd have $50,833 now!
![Doctor doing a telemedicine using laptop at a medical clinic](https://www.fool.com.au/wp-content/uploads/2023/09/health-23-16.9-400x225.jpeg)
Healthcare Shares
2 ASX biotech shares that could be the next Telix Pharmaceuticals
![four excited doctors with their hands in the air](https://www.fool.com.au/wp-content/uploads/2021/06/asx-share-price-17-400x225.jpg)
Healthcare Shares
Guess which ASX healthcare stock is rocketing 20% today
![a man looks down at his phone with a look of happy surprise on his face as though he is thrilled with good news.](https://www.fool.com.au/wp-content/uploads/2021/10/GettyImages-1189349093-1-400x225.jpg)
Share Gainers
Why Dimerix, Evolution, GQG, and Steadfast shares are climbing today
![A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face over these rising Tassal share price](https://www.fool.com.au/wp-content/uploads/2022/02/share-price-up-16.9-400x225.jpg)
Healthcare Shares
This ASX healthcare share has jumped 280% in just two days!
![Rocket powering up and symbolising a rising share price.](https://www.fool.com.au/wp-content/uploads/2022/02/rocket-2-16.9-400x225.jpg)
Healthcare Shares
Guess which ASX healthcare share is rocketing 130% on some big news
![Two lab technicians wearing white coats discuss results they see on a computer screen.](https://www.fool.com.au/wp-content/uploads/2021/10/GettyImages-1302454417-1-400x225.jpg)
Healthcare Shares
Dimerix (ASX:DXB) share price jumps on COVID study update
![A health worker wearing disposable gloves holds a vial, treating a patient.](https://www.fool.com.au/wp-content/uploads/2021/09/Trialling-new-treatment-16_9-400x225.jpg)
Healthcare Shares
Dimerix (ASX:DXB) share price soars as boss looks back on 'pivotal' year
![Medical staff wear hero capes, indicting strong shar [price performace for healthcare shares](https://www.fool.com.au/wp-content/uploads/2020/12/medical-400x225.jpg)
Share Gainers
These 3 ASX Healthcare shares have soared over 10% today
![A group of science or medical professionals cheering good news in the lab.](https://www.fool.com.au/wp-content/uploads/2021/07/Medical-professionals-cheering-good-news-400x225.jpg)
Healthcare Shares
Dimerix (ASX:DXB) share price soars 9% on COVID-19 news
DXB ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
---|---|---|---|---|---|
YesNo |
About Dimerix Ltd
A clinical stage drug discovery and development company. The operational headquarters of the company are in Melbourne, where Dimerix's lead clinical program is a Phase 2 study in Chronic Kidney Disease, DMX-200
DXB Share Price History Data provided by Morningstar.
Date | Close | Change | % Change | Volume | Open | High | Low |
---|---|---|---|---|---|---|---|
25 Jul 2024 | $0.47 | $-0.02 | -4.12% | 3,242,753 | $0.48 | $0.48 | $0.47 |
24 Jul 2024 | $0.49 | $-0.02 | -3.96% | 7,136,558 | $0.51 | $0.52 | $0.48 |
23 Jul 2024 | $0.51 | $-0.05 | -9.09% | 10,269,319 | $0.56 | $0.58 | $0.47 |
22 Jul 2024 | $0.55 | $-0.01 | -1.79% | 3,276,736 | $0.56 | $0.58 | $0.54 |
19 Jul 2024 | $0.56 | $0.04 | 7.62% | 3,991,693 | $0.52 | $0.57 | $0.51 |
18 Jul 2024 | $0.53 | $-0.02 | -3.70% | 3,666,765 | $0.53 | $0.54 | $0.51 |
17 Jul 2024 | $0.54 | $0.03 | 5.88% | 4,358,051 | $0.51 | $0.54 | $0.50 |
16 Jul 2024 | $0.51 | $0.04 | 8.42% | 6,544,552 | $0.48 | $0.54 | $0.48 |
15 Jul 2024 | $0.48 | $-0.02 | -4.08% | 5,746,927 | $0.50 | $0.50 | $0.47 |
12 Jul 2024 | $0.49 | $0.04 | 8.89% | 4,621,428 | $0.46 | $0.51 | $0.46 |
11 Jul 2024 | $0.45 | $-0.04 | -8.25% | 4,104,563 | $0.49 | $0.49 | $0.45 |
10 Jul 2024 | $0.49 | $0.05 | 11.36% | 4,271,716 | $0.44 | $0.49 | $0.44 |
09 Jul 2024 | $0.44 | $0.00 | 0.00% | 3,181,303 | $0.45 | $0.47 | $0.44 |
08 Jul 2024 | $0.44 | $-0.02 | -4.40% | 3,836,027 | $0.45 | $0.48 | $0.43 |
05 Jul 2024 | $0.46 | $-0.02 | -4.26% | 3,232,727 | $0.47 | $0.49 | $0.46 |
04 Jul 2024 | $0.47 | $0.00 | 0.00% | 11,383,528 | $0.47 | $0.49 | $0.41 |
03 Jul 2024 | $0.47 | $-0.06 | -11.43% | 6,664,473 | $0.52 | $0.52 | $0.46 |
02 Jul 2024 | $0.53 | $-0.01 | -1.89% | 771,943 | $0.53 | $0.54 | $0.52 |
01 Jul 2024 | $0.53 | $0.02 | 3.92% | 1,490,075 | $0.51 | $0.54 | $0.51 |
28 Jun 2024 | $0.51 | $0.00 | 0.00% | 3,301,397 | $0.52 | $0.55 | $0.51 |
27 Jun 2024 | $0.51 | $-0.04 | -7.34% | 2,822,901 | $0.54 | $0.54 | $0.50 |
26 Jun 2024 | $0.55 | $0.02 | 3.77% | 1,698,489 | $0.53 | $0.55 | $0.52 |
Director Transactions Data provided by Morningstar.
Date | Director | Type | Amount | Value | Notes |
---|---|---|---|---|---|
10 Apr 2024 | Nina Webster | Expiry | 25,000 | $7,625 |
Options expired.
|
10 Apr 2024 | Sonia Poli | Expiry | 37,500 | $11,437 |
Options expired. As per announcement on 03-06-2024
|
27 Mar 2024 | Nina Webster | Buy | 33,000 | $10,230 |
On-market trade.
|
26 Mar 2024 | Sonia Poli | Exercise | 12,501 | $1,575 |
Exercise of options.
|
26 Mar 2024 | Sonia Poli | Issued | 12,501 | $1,575 |
Exercise of options.
|
19 Mar 2024 | Nina Webster | Issued | 93,750 | $11,812 |
Exercise of options.
|
19 Mar 2024 | Nina Webster | Exercise | 93,750 | $11,812 |
Exercise of options.
|
01 Dec 2023 | Nina Webster | Issued | 2,052,956 | $282,675 |
Employee Share Ownership Plan. Black-Scholes valuation
|
30 Oct 2023 | Nina Webster | Expiry | 6,351,975 | $1,079,835 |
Options expired.
|
Directors & Management Data provided by Morningstar.
Name | Title | Start Date | Profile |
---|---|---|---|
Mr Mark P Diamond | Non-Executive Director | Dec 2023 |
--
|
Mr Hugh Alsop | Non-Executive Director | May 2017 |
Mr Alsop is an accomplished and commercially focused executive with experience in international business development, partnering, drug development and leadership of scientific teams. Hugh is currently CEO of Kinoxis Therapeutics, a private company developing novel therapeutics for substance use disorders and other neurological conditions. Prior to Kinoxis, Hugh was CEO of venture-backed private company Hatchtech, where he was responsible for several drug development programs for the international markets. Hugh is also a non Executive Director of private companies Servatus Ltd, Eflare Corporation Pty Ltd, Avalyn Australia Pty Ltd, AnaptysBio Pty Ltd and Lassen Therapeutics1 Pty Ltd.
|
Ms Nina Webster | Chief Executive OfficerManaging Director | Aug 2018 |
Ms Webster has experience in the pharmaceutical industry, with leadership roles across strategy, commercialisation, intellectual property, scientific and operational aspects of product development.Nina worked in large Pharma, Wyeth Pharmaceuticals (UK). Nina is also a Non-Executive Director of Linear Clinical Research Limited and SYNthesis BioVentures Pty Ltd.
|
Dr Sonia Maria Poli | Non-Executive Director | Jul 2015 |
Ms Poli is an accomplished R&D professional with 20 years international experience in large and small pharmaceutical companies. Sonia is currently serving as advisor for several late stage drug development projects approaching market authorization. Sonia was formerly Executive Manager at AC Immune,Nasdaq listed company, and Chief Scientific Officer at Minoryx and Addex Therapeutics and she has previously worked within Swiss Stock Exchange listed companies Hoffman la Roche.
|
Mr Clinton Snow | Non-Executive Director | May 2023 |
Mr Snow has 20 years experience as a technology leader with a focus in engineering management, project delivery, risk management and assurance. Clinton is providing advisory services to a family office with multiple Australian biotech investments.
|
Mr Hamish George | Chief Financial OfficerCompany Secretary | May 2019 |
-
|
Hamish George | Chief Financial OfficerCompany Secretary |
-
|
Top Shareholders Data provided by Morningstar.
Name | Shares | Capital |
---|---|---|
Mr Peter Fletcher Meurs | 35,572,412 | 9.08% |
Skiptan Pty Ltd <P&M Meurs Family A/C> | 29,357,028 | 7.50% |
Freedom Trader Pty Ltd | 9,375,152 | 2.39% |
Bavaria Bay Pty Ltd | 7,316,992 | 1.87% |
Yodambao Pty Ltd | 6,362,603 | 1.62% |
Mrs Melinda Jane Coates & Mr Andrew Joseph Coates | 5,000,000 | 1.28% |
Mrs Julie Maree Scott | 4,425,000 | 1.13% |
Mr Philip Robert Scott | 4,425,000 | 1.13% |
Mr Andrew Joseph Coates & Mrs Melinda Jane Coates | 4,311,500 | 1.10% |
Mr Richard Stanley De Ravin | 4,200,000 | 1.07% |
Tamer Yigit Property Group Pty Ltd | 3,870,000 | 0.99% |
Mr Taylor Nicholas Green | 3,500,000 | 0.89% |
Mr Anthony Mark Van Der Steeg | 3,090,519 | 0.79% |
Limnos 34 Pty Ltd | 3,000,728 | 0.77% |
Mrs Gwen Murray Pfleger | 2,807,984 | 0.72% |
Rubi Holdings Pty Ltd | 2,500,000 | 0.64% |
Coates Family Office Pty Ltd | 2,300,000 | 0.59% |
Toroha Pty Ltd | 2,137,753 | 0.55% |
Solequest Pty Ltd | 2,000,000 | 0.51% |
Moore Family Nominees Pty Ltd | 2,000,000 | 0.51% |
Citicorp Nominees Pty Limited | 1,953,707 | 0.50% |
Jampaso Pty Ltd | 1,778,742 | 0.45% |